SomnoMed Ltd (OTCPK:SOMNF)
$ 0.1653 0 (0%) Market Cap: 62.07 Mil Enterprise Value: 56.16 Mil PE Ratio: 0 PB Ratio: 2.22 GF Score: 48/100

Full Year 2021 Somnomed Ltd Earnings Call Transcript

Aug 24, 2021 / 01:00AM GMT
Release Date Price: $1.72
Operator

Thank you for standing by. Welcome to the SomnoMed 2021 Full Year Results Conference Call. (Operator Instructions)

I would now like to turn the conference call over to Mr. Neil Verdal-Austin, CEO. Sir, the floor is yours.

Neil Verdal;Austin
SomnoMed Limited - CEO, MD & Director

Good morning, ladies and gentlemen, and welcome to SomnoMed's webcast of the FY '21 results. As said, my name is Neil Verdal-Austin, and I'm the CEO of this extraordinary company. We also trust that everyone is well and doing all that you can do to remain safe during this very difficult time.

Fiscal year '21 was certainly a challenge, not only for SomnoMed but for everyone throughout the world. The fiscal year began 4 months into a global pandemic that created much uncertainty and unfortunately, continues to do so today. SomnoMed, I'm pleased to say, has managed through this initial COVID-19 period extremely well.

And after the usual disclaimer slide, it gives me great pleasure to start at Slide 4, our financial and fiscal year '21

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot